Jackson Creek Investment Advisors LLC Intercept Pharmaceuticals, Inc. Transaction History

Jackson Creek Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$12.53 - $21.71 $200 - $347	-16 Reduced 0.03%	53,116 $713,000
Q4 2022 Feb 03, 2023	SELL	$11.61 - $16.11 $49,505 - $68,693	-4,264 Reduced 7.43%	53,132 $657,000
Q3 2022 Nov 09, 2022	SELL	$12.21 - $19.7 $1,050 - $1,694	-86 Reduced 0.15%	57,396 $801,000
Q2 2022 Aug 04, 2022	SELL	$11.23 - $19.59 $52,814 - $92,131	-4,703 Reduced 7.56%	57,482 $733,000
Q1 2022 May 03, 2022	BUY	$13.37 - $17.79 $35,149 - $46,769	2,629 Added 4.41%	62,185 $1.01 Million
Q4 2021 Feb 01, 2022	BUY	$14.28 - $19.53 $850,459 - $1.16 Million	59,556 New	59,556 $970,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.